BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32752061)

  • 1. Food-Derived Nanoscopic Drug Delivery Systems for Treatment of Rheumatoid Arthritis.
    Han D; Chen Q; Chen H
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32752061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine for Intra-Articular Drug Delivery in Rheumatoid Arthritis.
    O'Mary H; Del Rincόn I; Cui Z
    Curr Med Chem; 2016; 23(23):2490-506. PubMed ID: 27237822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Delivery System Approaches for Rheumatoid Arthritis Treatment: A Review.
    Garhwal A; Kendya P; Soni S; Kori S; Soni V; Kashaw SK
    Mini Rev Med Chem; 2024; 24(7):704-720. PubMed ID: 37711105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical nanocarriers for management of Rheumatoid Arthritis: A review.
    Anita C; Munira M; Mural Q; Shaily L
    Biomed Pharmacother; 2021 Sep; 141():111880. PubMed ID: 34328101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate Aspasomes Against Rheumatoid Arthritis: Optimized Hydrogel Loaded Liposomal Formulation with In Vivo Evaluation in Wistar Rats.
    Ghosh S; Mukherjee B; Chaudhuri S; Roy T; Mukherjee A; Sengupta S
    AAPS PharmSciTech; 2018 Apr; 19(3):1320-1336. PubMed ID: 29340978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coated nanostructured lipid carriers targeting the joints - An effective and safe approach for the oral management of rheumatoid arthritis.
    Zewail M; Nafee N; Helmy MW; Boraie N
    Int J Pharm; 2019 Aug; 567():118447. PubMed ID: 31226475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate: a gold standard for treatment of rheumatoid arthritis.
    Shinde CG; Venkatesh MP; Kumar TM; Shivakumar HG
    J Pain Palliat Care Pharmacother; 2014 Dec; 28(4):351-8. PubMed ID: 25322199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate-loaded lipid-core nanocapsules are highly effective in the control of inflammation in synovial cells and a chronic arthritis model.
    Boechat AL; de Oliveira CP; Tarragô AM; da Costa AG; Malheiro A; Guterres SS; Pohlmann AR
    Int J Nanomedicine; 2015; 10():6603-14. PubMed ID: 26543364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nano-platform Strategies of Herbal Components for the Management of Rheumatoid Arthritis: A Review on the Battle for Next-Generation Formulations.
    Prabha J; Kumar M; Kumar D; Chopra S; Bhatia A
    Curr Drug Deliv; 2024; 21(8):1082-1105. PubMed ID: 37622715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional folate receptor-targeting and pH-responsive nanocarriers loaded with methotrexate for treatment of rheumatoid arthritis.
    Zhao J; Zhao M; Yu C; Zhang X; Liu J; Cheng X; Lee RJ; Sun F; Teng L; Li Y
    Int J Nanomedicine; 2017; 12():6735-6746. PubMed ID: 28932117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear Factor kappa B (NF-κB) Targeted Self-Assembled Nanoparticles Loaded with Methotrexate for Treatment of Rheumatoid Arthritis.
    Li X; Qu J; Zhang T; He X; Jiang Y; Chen J
    Med Sci Monit; 2019 Nov; 25():8204-8212. PubMed ID: 31674342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate-conjugated hydrophobicity modified glycol chitosan nanoparticles for targeted delivery of methotrexate in rheumatoid arthritis.
    Wu Z; Xu K; Min J; Chen M; Shen L; Xu J; Jiang Q; Han G; Pan L; Li H
    J Appl Biomater Funct Mater; 2020; 18():2280800020962629. PubMed ID: 33155513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and evaluation of biopolymeric nanoparticles as drug delivery system in effective treatment of rheumatoid arthritis.
    Kumar V; Leekha A; Tyagi A; Kaul A; Mishra AK; Verma AK
    Pharm Res; 2017 Mar; 34(3):654-667. PubMed ID: 28097508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Rheumatoid Arthritis by Serum Albumin Nanoparticles Coated with Mannose to Target Neutrophils.
    Lyu J; Wang L; Bai X; Du X; Wei J; Wang J; Lin Y; Chen Z; Liu Z; Wu J; Zhong Z
    ACS Appl Mater Interfaces; 2021 Jan; 13(1):266-276. PubMed ID: 33379867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New autoinjector technology for the delivery of subcutaneous methotrexate in the treatment of rheumatoid arthritis.
    Schiff M; Jaffe J; Freundlich B; Madsen P
    Expert Rev Med Devices; 2014 Sep; 11(5):447-55. PubMed ID: 24934630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous inspired biomineral-installed hyaluronan nanoparticles as pH-responsive carrier of methotrexate for rheumatoid arthritis.
    Alam MM; Han HS; Sung S; Kang JH; Sa KH; Al Faruque H; Hong J; Nam EJ; Kim IS; Park JH; Kang YM
    J Control Release; 2017 Apr; 252():62-72. PubMed ID: 28288894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel drug delivery systems for NSAIDs in management of rheumatoid arthritis: An overview.
    Thakur S; Riyaz B; Patil A; Kaur A; Kapoor B; Mishra V
    Biomed Pharmacother; 2018 Oct; 106():1011-1023. PubMed ID: 30119166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of folate-conjugated glycol-chitosan nanoparticles in modulating the activated macrophages to ameliorate inflammatory arthritis: in vitro and in vivo activities.
    Kumar V; Leekha A; Kaul A; Mishra AK; Verma AK
    Drug Deliv Transl Res; 2020 Aug; 10(4):1057-1075. PubMed ID: 32363539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridging the gap in rheumatoid arthritis treatment with hyaluronic acid-based drug delivery approaches.
    Priya S; Daryani J; Desai VM; Singhvi G
    Int J Biol Macromol; 2024 Jun; 271(Pt 1):132586. PubMed ID: 38795889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleic Acids for Potential Treatment of Rheumatoid Arthritis.
    Sun P; Su J; Wang X; Zhou M; Zhao Y; Gu H
    ACS Appl Bio Mater; 2022 May; 5(5):1990-2008. PubMed ID: 35118863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.